Dr Reddys Laboratories Ltd
RDY- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001135951
No open-market purchases or sales by Dr Reddys Laboratories Ltd insiders were filed in the last 90 days; 239 institutions reported holding it in 13F filings for Q2 2026, worth $1.82B in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Dr Reddys Laboratories Ltd changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 161 | 2 | 150 | −9 |
| Shares | 18.4M | 10.8K | 17.0M | −1.41M (−7.7%) |
| Value | $1.35B | $793.0K | $1.11B | −$245.2M (−18.1%) |
2 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (11)
Institutions that held Dr Reddys Laboratories Ltd at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| B. Metzler seel. Sohn & Co. Holding AG | 21,052 | $1.37M | 0.02% |
| CIBC World Markets Inc. | 12,600 | $821.0K | 0.00% |
| Smith Group Asset Management, LLC | 11,690 | $761.0K | 0.04% |
| LMR Partners LLP | 7,726 | $508.0K | 0.01% |
| Two Sigma Advisers, LP | 5,500 | $358.0K | 0.00% |
| Hexavest Inc. | 3,402 | $222.0K | 0.01% |
| XTX Topco Ltd | 3,118 | $203.0K | 0.07% |
| Wolverine Trading, LLC | 3,090 | $201.0K | 0.00% |
| D'Orazio & Associates, Inc. | 310 | $20.0K | 0.00% |
| Meridian Wealth Partners, LLC | 114 | $7.00K | 0.00% |
| Glassman Wealth Services | 14 | $1.00K | 0.00% |
Sold out (20)
Institutions that held Dr Reddys Laboratories Ltd at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Fiera Capital Corp | 72,014 | $5.29M |
| Jupiter Asset Management Ltd | 18,692 | $1.37M |
| Qube Research & Technologies Ltd | 14,879 | $1.09M |
| National Asset Management, Inc. | 12,340 | $908.0K |
| Manufacturers Life Insurance Company, The | 9,069 | $667.0K |
| Comerica Bank | 9,345 | $585.0K |
| West Family Investments, Inc. | 7,457 | $548.0K |
| Ameriprise Financial Inc | 6,231 | $458.0K |
| Creative Planning | 4,550 | $334.0K |
| Blueshift Asset Management, LLC | 4,494 | $330.0K |
| Sompo Asset Management Co., Ltd. | 3,460 | $254.0K |
| Guggenheim Capital LLC | 3,331 | $245.0K |
| Jane Street Group, LLC | 3,169 | $233.0K |
| Balentine LLC | 3,144 | $231.0K |
| Eqis Capital Management, Inc. | 3,100 | $228.0K |
| Fernwood Investment Management, LLC | 3,000 | $221.0K |
| Caxton Associates LP | 2,983 | $219.0K |
| Wedbush Securities Inc | 2,768 | $204.0K |
| FORA Capital, LLC | 560 | $41.0K |
| Enterprise Financial Services Corp | 354 | $26.0K |
Not filed for Q3 2021 yet (2)
Institutions that held Dr Reddys Laboratories Ltd at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Smith Asset Management Group LP | 10,300 | $757.0K |
| CWM, LLC | 493 | $36.0K |